C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
530/7.64, 167/10
C07K 7/64 (2006.01) A61K 38/13 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1338728
Cyclosporins wherein the residue at the 1-position (typically -MeBmt- or -dihydro-MeBmt-) is 3'0-acylated or 3'-oxo or -C1-4 alkoxyimino substituted, or wherein the residue at the 2-position is .beta.-0-acyl or .beta.-oxo substituted, or wherein the residue at the 2-position is -Ile-, or wherein the residue at the 11-position is -MeAla-, -MeIle- or -MealloIle- as well as various naturally occurring cyclosporins/dihydro-derivatives thereof, are useful in reversing resistance to chemotherapy, in particular resistance to cytostatic or anti-neoplastic therapy. Various of these cyclosporins and intermediates for their production are novel. Intermediates wherein the residue (e.g. -MeBmt-, -dihydro-MeBmt- etc.) at the 1-position is 8'-alkoxy or 7'-desmethyl-7'-hydrocarbyl substituted are novel and useful as immunosuppressants, anti-inflammatory and anti-parasitic agents.
569523
Bollinger Pietro
Bolsterli Johann Jakob
Borel Jean Francois
Krieger Manfred
Payne Trevor Glyn
Bollinger Pietro
Bolsterli Johann Jakob
Borel Jean Francois
Fetherstonhaugh & Co.
Krieger Manfred
LandOfFree
Cyclosporins and their use a pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclosporins and their use a pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclosporins and their use a pharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1321042